Concord-Carlisle High School students designed and built hydraulic robotic arms, showcasing their engineering skills.

India's top seven housing markets saw a muted 2 per cent growth in average prices during January-March against the previous ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Kimber Streams Kimber Streams is a writer who has been covering laptops and ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

After teasing a plasma-based manufacturing expansion in the U.S. late last year, CSL is putting in the work and firming up details behind the $1.5 billion project. Monday, the Australian biopharma ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Melbourne-based company will ...

(The Center Square) – A global biopharmaceutical company has announced it will invest $1.5 billion for a new manufacturing facility in Bradley, but the taxpayer cost of the project is unknown. On ...

Eli Lilly has been scouting for drugs to follow the trail blazed by its blockbuster cardiometabolic medicines. Its latest pipeline-building deal has the pharmaceutical company paying $100 million for ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

Feb ⁠18 (Reuters) - ⁠Australia's CSL said on Wednesday it had entered into an exclusive ⁠licensing ⁠agreement with ⁠Eli Lilly and Co, granting it certain ⁠rights to develop ⁠and commercialise ...

CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...